WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • May 19th, 2015 • MYOS Corp • Pharmaceutical preparations
This Warrant Exercise Agreement (this “Agreement”), dated as of May 18, 2015, is by and between MYOS Corporation, a Nevada corporation (the “Company”) and the undersigned holder (the “Holder”) with respect to that certain Series D Common Stock Purchase Warrant issued by the Company, which warrant is exercisable until May 18, 2015 at an exercise price (the “Exercise Price”) of $9.37 per share (the “Series D Warrant”).
